MAPT and age-related macular degeneration: It is our hope that remarking on this phenomenon encourages additional research into the utilization of these previous reports to mediate early diagnosis of AMD (i.e., Aβ, tau, inflammation, microglial activation), and that emerging treatments for AD (anti-amyloid, anti-tau) in conjunction with reduced CS might be useful for the treatment of AMD.